Effects of Prostaglandin E₂ on Brain Edema and Liver Histopathology in A Galactosamine-Induced Fulminant Hepatic Failure Rat Model

References

• Decker K., Keppler D. Galactosamine induced liver injury. Chap. 11. Progress in liver disease, H Popper, F Schaffner. Grune and Stratton, New York 1972; Vol. 4
   Google Scholar
• Pickering R W, James G WL, Porter FL. An investigation of some parameters that affect the galactosamine model of hepatitis in the rat. Arzneim.-Forsch (Drug Res) 1975; 25(6)898–901.
   PubMedGoogle Scholar
• Saunders SJ. Experimental models of hepatic failure. Hepatology IX, Freiburg. Falk Foundation. 1979; ix–xi
   Google Scholar
• Blitzer B L, Waggoner J G, Jones E A, et al. A model of fulminant hepatic failure in the rabbit. Gastroenterology 1978; 74(4)664–71
   PubMedGoogle Scholar
• Niu Z, Shu C D, Jia S R, Li SM. Factors possibly influencing the effects of hemoperfusion in fulminant hepatic failure rats. Past, Present and Future of Artificial Organs, E Piskin, TMS Chang. Meteksan Publishing Co., Ankara, Turkey 1983; 140–151
   Google Scholar
• Chirito E, Reiter B, Lister C, Chang T MS. Artificial liver: The effect of ACAC microencapsulated hemoperfusion on fulminant hepatic failure. Artif Organs 1977; 1(1)76–83
   PubMedGoogle Scholar
• Chang T MS, Lister C, Chirito E, O'Keefe P, Resurreccion E. Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats. Trans Am Soc Artif Intern Organs 1978; 24: 243–45
   PubMedGoogle Scholar
• Chirito E, Lister C, Chang T MS. Biochemical hematological and histological changes in a fulminant hepatic failure rat model for artificial liver assessment. Artif Organs 1979; 3(1)42–6
   PubMedGoogle Scholar
• Chang T MS, Lister C. Analysis of possible toxins in hepatic coma including the removal of mercaptan by albumin-collodion charcoal. Int J Artif Organs 1980; 3(2)108–12
   PubMedGoogle Scholar
• Mohsini K, Lister C, Chang T MS. The effects of homologous cross-circulation and in situ liver perfusion on fulminant hepatic failure rats. Artif Organs 1980; 4: 171–75
   PubMedGoogle Scholar
• Tabata Y, Chang T MS. Comparisons of six artificial liver support regimes in fulminant hepatic coma rats. Trans Am Soc Artif Intern Organs 1980; 26: 394–99
   PubMedGoogle Scholar
• Chang T MS, Lister C. Middle molecules in hepatic coma and uremia. Artif Organs 1981; 4: 169–72, supp
   PubMedGoogle Scholar
• Chang T MS. Hemoperfusion, exchange transfusion, cross circulation, liver perfusion, hormones and immobilized enzymes. Artificial Liver Support, G Brunner, FW Schmidt. Springer-Verlag, Berlin 1981; 126–133
   Google Scholar
• Dixit V, Chang T MS. Soluble liver extracts as supplement to detoxification by hemoperfusion. Int J Artif Organs 1981; 4: 291–94
   PubMed Web of Science ®Google Scholar
• Shi Z Q, Chang T MS. The effects of hemoperfusion using coated charcoal or tyrosinase artifical cells on middle molecules and tyrosine in brain serum of hepatic coma rats. Trans. Am. Soc. Artif. Internal Organs 1982; 28: 205–9
   PubMedGoogle Scholar
• Dixit V, Chang T MS. Effects of prostaglandin E2on the survival time of fulminant hepatic failure rats. Int J Artif Organs 1982; 5: 388
   PubMed Web of Science ®Google Scholar
• Shu C D, Chang T MS. Middle molecules in the serum, brain, liver and urine of galactosamine-induced fulminant hepatic failure rats. Int J Artif Organs 1983; 6: 273–77
   PubMedGoogle Scholar
• Chang T MS. Liver support systems. Life Support Systems in Intensive Care, Bartlett. Year Book Publisher. 1984; 461–85
   Google Scholar
• Dixit V, Chang T MS. Preliminary report on the effects of prostaglandin E2on brain edema in fulminant hepatic failure rats. Int J Artif Organs 1985; 8: 55–56
   PubMedGoogle Scholar
• Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979; 77: 761–67
   PubMed Web of Science ®Google Scholar
• Stachura J, Tarnawski A, Szczudrawa J, Bogdae J, Mach T, Klimczyk B, Kirchmayer S. Cytoprotective effects of 16,16 dimethyl prostaglandin E2and some drugs on acute galactosamine induced liver damage in rat. Folia Histochem Cytochem 1980; 9: 311–18
   Google Scholar
• Miyazaki M, Makowka L, Falk R E, Falk J A, McDonnel M, Venturi D. Protection of thermohemotherapeutic-induced lethal acute hepatic necrosis in the rat by 16,16, dimethyl prostaglandin E2. J Surg Res 1983; 34(5)415–426.
   PubMedGoogle Scholar
• Stachura J, Tarnowski A, Ivey K J, Ruwart M J, Rush B D, Friedle N M, Szezudrawa J, Mach T. 16, 16-dimethyl prostaglandin E2protection of rat liver against acute injury by galactosamine, acetomenophen, ethanol, and ANIT. Gastroenterology 1981; 80: 1349
   Google Scholar
• Loginov A S, Markova MN. Prostaglandins in liver disease. Materia Medica Polona 1979; 2(29)91–99
   Google Scholar
• Trewby P, Bennett A, Murray-Lyon I M, Williams R. Plasma prostaglandins in fulminant hepatic failure. Br Med J 1975; 4: 442
   PubMedGoogle Scholar
• Gazzard B G, Portmann B, Murray-Lyon I M, Williams R. Causes of death in fulminant heptic failure and relationship to quantitative histological assessment of parenchymal damage. Quart J Med 1975; 176: 615–626
   Google Scholar
• Hayat M AR. Principles and Techniques of Electron Microscopy. Van Nostrand Reinhold Co., New York 1970
   Google Scholar
• Rapoport SI. Blood Brain Barrier in Physiology and Medicine. Raven Press, New York 1976
   Google Scholar
• Livingston A S, Potrin M, Goresky C A, Finlayson M H, Hinchey EJ. Changes in the blood brain barrier in hepatic coma after hepatectomy in the rat. Gastroenterology 1977; 73: 697–704
   PubMedGoogle Scholar
• Go KG. Physical methods for study of brain edema. Advances in Neurology, J Cervos, R. Navarro, R Ferszt. Brain Edema Raven Press, New York 1980; Vol. 28: 1–8
   Google Scholar
• Hammerstrom S. Biosynthesis and biological actions of prostaglandins and thromboxanes. Arch Biochem Biophys 1982; 214(2)431–445
   PubMedGoogle Scholar
• Wolfe LS. Possible roles of protaglandins in the nervous system. Advances in Neurochemistry, BW Agraniff, MH Aprison. Plenum Press, New York 1975; vol.l: l–49
   Google Scholar
• Scda H WM, Hughes R D, Gove C D, Williams R. Removal of inhibitors of brain Na+K+-AT Pase by hemoperfusion in fulminant hepatic failure. Artificial Organs 1984; 8(2)174–78
   PubMedGoogle Scholar